Mannkind (MNKD) Current Leases (2021 - 2024)
Mannkind (MNKD) reported Current Leases of $9.9 million for Q1 2024, up 3.12% year-over-year from $9.6 million in Q2 2023, and up 0.93% on a QoQ basis from $9.8 million in Q4 2023.
Mannkind (MNKD) has 4 years of Current Leases data on file, last reported at $9.9 million in Q1 2024.
- Quarterly Current Leases rose 3.12% year-over-year to $9.9 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $9.9 million (up 3.12% YoY) and the FY2023 annual result came in at $9.8 million, up 2.18% from the prior year.
- Current Leases climbed to $9.9 million in Q1 2024 per MNKD's latest filing, from $9.8 million in the prior quarter.
- Across five years, Current Leases topped out at $9.9 million in Q1 2024 and bottomed at $7.0 million in Q4 2021.
- The 4-year median for Current Leases is $9.6 million (2022), against an average of $9.4 million.
- The widest annual swing landed in 2022, when Current Leases surged 37.59%; it then gained 1.96% in 2023.
- Tracing MNKD's Current Leases over 4 years: stood at $7.0 million in 2021, then jumped by 37.59% to $9.6 million in 2022, then increased by 2.18% to $9.8 million in 2023, then advanced by 0.93% to $9.9 million in 2024.
- Per Business Quant, the three latest MNKD Current Leases figures stand at $9.9 million (Q1 2024), $9.8 million (Q4 2023), and $9.7 million (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 9.90 Mn |
| Dec 31, 2023 | 9.81 Mn |
| Sep 30, 2023 | 9.75 Mn |
| Jun 30, 2023 | 9.69 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 9.60 Mn |
| Sep 30, 2022 | 9.53 Mn |
| Jun 30, 2022 | 9.50 Mn |
| Mar 31, 2022 | 9.41 Mn |
| Dec 31, 2021 | 6.98 Mn |